Outcomes Following Treatment of Maternal Hypercalcemia Due to CYP24A1 Pathogenic Variants.

ABSTRACT:

SUBMITTER: McBride L 

PROVIDER: S-EPMC6551508 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature